Serum Clara cell protein as an indicator of pulmonary impairment in occupational exposure at aluminum foundry

International Journal of Occupational Medicine and Environmental Health

Volumn 19, Issue 4, 2006, Pages 211-223

  Hałatek, Tadeusz ^a   Trzcinka Ochocka, Małgorzata ^a   Matczak, Wanda ^a   Gruchała, Jacek ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Aluminum; Clara cell protein; Foundry; Occupational exposure; Respiratory system

Indexed keywords

ALUMINUM; CLARA CELL PROTEIN; EOSINOPHIL CATIONIC PROTEIN; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN E; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DUST EXPOSURE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FOUNDRY; HUMAN; HUMAN EXPERIMENT; IRON BLOOD LEVEL; LUNG DISEASE; MALE; OCCUPATIONAL EXPOSURE; RESPIRATORY FUNCTION; RESPIRATORY SYSTEM; SMELTER; SPIROMETRY; URINALYSIS;

EID: 33846815162     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10001-006-0033-6     Document Type: Article

References (101)

1. Abbate C, Giorgianni C, Brecciaroli R, Tringali MA, D'Arrigo G. Spirometric function in non-smoking workers exposed to aluminum. Am J Ind Med 2003;44:400-4.
2. Abramson MJ, Włodarczyk JH, Saunders NA, Hensley MJ. Does aluminium smelting cause lung disease? State of the art. Am Rev Respir Dis 1998;139:1042-57.
3. Soyseth V, Kongerund J, Boe J, Fonneland T. Bronchial responsiveness and work-related asthma in aluminium potroom workers effect of removal from exposure. Europ Resp J 1992;5:829-33.
4. Kongerund J, Boe J, Soyseth V, Naalsund A, Magnus P. Aluminium potroom asthma: the Norwegian experience. Eur Resp J 1994;7:165-72.
5. O'Donnell T. Asthma and respiratory problems - a review. Sci Total Environ 1995;163:137-45.
6. Sorgdrager B, de Looff AJ, de Monchy JG, Pal TM, Dubois AE, Rijcken B. Occurrence of occupational asthma in aluminium potroom workers in relation to preventive measures. Int Arch Occup Environ Health 1998;71:53-5.
7. Vandenplas O, Delwich JP, Vanblisen ML, Joly J, Roosels D. Occupational asthma caused by aluminium welding. Eur Respir J 1998;11:1182-4.
8. Barnard CG, McBride DI, Firth HM, Herbison GP. Assessing individual employee risk factors for occupational asthma in primary aluminium smelting. Occup Environ Med 2004;61:604-8
9. Sjaheim T, Halstensen TS, Lund MB, Bjortuft O, Drablos PA, Malterud D, et al. Airway inflammation in aluminium potroom asthma. Occup Environ Med 2004;61:779-85.
10. WHO. Aluminium. International Programme on Chemical Safety. Environmental Health Criteria 194. Geneve: World Health Organization; 1997.
11. Sjorgen B, Blinder CG, Iregren A, McLachlan DRC, Riihimaki V. Occupational aluminium exposure and its health effects. In: Yokel RA, Golub MS, editors. Reserch Issues in Aluminium Toxicity. USA: Toxicity Yaylor and Francis; 1997. pp. 165-183.
12. ACGIH. Threshold Limit Values for Chemical Substances and Physical Agents. Washington: American Conference of Governmental Industrial Hygienists; 2001.
13. WHO. Biomarkers and risk assessment: concepts and principles. International Programme on Chemical Safety. Environmental Health Criteria 155. Geneve: World Health Organization; 1993.
14. Mantile G, Miele L, Cordella-Miele E, Singh G, Katyal SL, Mukherjee AB. Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. J Biol Chem 1993;268:565-75.
15. Lesur O, Bernard A, Arsalane K, Lauwerys R, Begin R, Cantin A et al. Clara cell protein (CC16) induces a Phospholipase A2-mediated inhibition of fibroblasts migration in vitro. Am J Respir Crit Care Med 1995;152:290-7.
16. Singh G, Katyal SL. Clara cells and Clara cell 10 kD protein (CC10). Am J Respir Cell Mol Biol 1997;17:141-3.
17. Hałatek T, Hermans C, Broeckaert F, Wattiez R, Wiedig M, Toubeau G, et al. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Resp J 1998;11:726-33.
18. Hałatek T, Trzcinka-Ochocka M, Matczak W, Krajewska B. Studies on the relationship between occupational exposure to manganese and serum Clara cell protein levels in shipyard workers. Trace Elem Electrolytes 2000;17:48-53.
19. Hałatek T, Opalska B, Świercz R, Pałczyński C, Górski P, Rydzyński K, et al. Glutaraldehyde inhalation exposure of rats: Effects on morphology of the kings and Clara cell protein and hyaluronic acid levels in BAL. Inhal Toxicol 2003;15:85-97.
20. Hałatek T, Opalska B, Wȩgrowski Y. Clara cell protein and metallopmteinase level in BALF after alumina dust-induced lung injury. In: Marone G, editor. Clinical Immunology and Allergy in Medicine. Naples, Italy: JGC Edition; 2003. pp. 307-11.
21. Hałatek T, Wrońska-Nofer T, Gruchała J, Trzcinka-Ochocka M, Stetkiewicz J, Rydzyński K. Pneumotoxic effects of welding fumes: Cross-week evaluation of Clara cell protein and manganese in blood of shipyard workers. Trace Elem Electrolytes 2004;21:16-22.
22. 2-microglobulin as early markers of occupational exposure to nitric oxides. Inhal Toxicol 2005;17:87-95.
23. Hałatek T, Opalska B, Lao I, Stetkiewicz J, Rydzyński K. Pneumotoxicity of dust from aluminum foundry and pure alumina: comparative morphological, and biomarkers study in rats Int J Occup Environ Health 2005;18:51-62.
24. Marimoto Y, Tanaka I. In vivo studies of man-made mineral fibers-fibrosis-related factors. Ind Health 2001;39:106-13.
25. Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2001;163:185-94.
26. Ekberg-Jansson A, Andersson B, Bake B, Boijsen M, Enanden I, Rosengren A, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med 2001;95:363-73.
27. Shijubo N, Itoh Y, Yamaguchi T, Imada A, Hirasawa M, Yamada T, et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am J Respir Crit Care Med 1999;160:930-3.
28. Sharma S, Ghosh B. Association of an intragenic microsatellite marker in the CC16 gene with asthma in the Indian population. J Hum Genet 2004;49:677-83.
29. Ye Q, Fujita M, Ouchi H, Inoshima I, Maeyama T, Kuwano K, et al. Serum CC-10 in inflammatory lung diseases. Respiration 2004;71:505-10.
30. Reader JR, Tepper JS, Schelegle ES, Aldrich MC, Putney LF, Pfeiffer JW, et al. Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol 2003;162:2069-78.
31. Hayashi T, Ishii A, Nakai S, Hasegawa K. Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch 2004;444:66-73.
32. Shijubo N, Itoh Y, Yamaguchi T, Shibuya Y, Morita Y, Hirasawa M, et al. Serum and BAL Clara cell 10 kDa protein (CC 10) levels and CC 10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997;10:1108-14.
33. Field GB. Pulmonary function in aluminium smelters. Thorax 1984;39:743-51.
34. Saric M, Godnic-Cvar J, Gomzi M, Stilinovic L. The role of atopy in potroom workers'asthma. Am J Ind Med 1986;9:239-42.
35. Saric M, Marelja J. Bronchial hyperreactivity in potroom workers and prognosis after stopping exposure. Br J Ind Med 1991;48:653-5.
36. Kilburn KH, Warshaw RH. Irregular opacities in the lung, occupational asthma, and airways dysfunction in aluminum workers. Am J Ind Med 1992;21:845-53.
37. San LN, Uysal H, Gokbel H, Bediz CS, Sayal A. Pulmonary function of workers in the aluminum industry. Am J Ind Med 1998;33:305-7.
38. Radon K, Nowak D, Heinrich-Ramm R, Szadkowski D. Respiratory health and fluoride exposure in different parts of the modern primary aluminum industry. Int Arch Occup Environ Health 1999;72:297-303.
39. 1 and exposure to dust and tobacco smoke in aluminium potroom workers. Occup Environ Med 1997;54:27-31.
40. Kraus T, Schaller KH, Angerer J, Letzel S. Aluminium dust-induced lung disease in the pyro-powder-producing industry: detection by high-resolution computed tomography. Int Arch Occup Environ Health 2000;73:61-4.
41. Sjogren B, Elinder CG, Lidums V, Chang G. Uptake and urinary excretion of aluminium among welders. Int Arch Occup Environ Health 1988;60:77-9.
42. Apostoli P, Lucchini R, Maccarrone R, Alessio L. Biological monitoring of occupational exposure to aluminum. Med Lav 1992;83:475-83.
43. Rollin HB, Theodorou P, Cantrell AC. Biological indicators of exposure to total and respirable aluminum dust fraction in a primary aluminium smelter. Occup Environ Med 1996;53:417-21.
44. Razniewska G, Trzcinka-Ochocka M. ET-AAS as a method for determination of aluminium in blood serum and urine. Chem Anal (Warsaw) 2003;48:107-13.
45. Zilva JR, Pannall PR. Iron metabolism in Clinical Chemistry in Diagnosis and Treatment. Lloyd-Luke Chap 1979;18:378-92.
46. Bernard A, Lauwerys R, Noel A, Vandeleene B, Lambert A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin Chim Acta 1991;201:231-45.
47. Hałatek T, Jakubowski M. Latex-immunological method of determination of micromolecular proteins and albumin in urine. I. Description of the method. Med Pr 1991;42:77-88 [in Polish].
48. Habig W, Pabst MJ, Jacoby W. Glutathione S-transferase: the first step in mercapturic acid formation. J Biol Chem 1974;249:7130-9.
49. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable gels. Anal Biochem 1971;44:276-87.
50. Hoffstein ST. Intra- and extracellular secretion from polymorphonuclear leucocytes. Weissman G, editor. In: The Cell Biology of Inflammation. Amsterdam: Elsevier North Holland; 1980. pp. 387-430.
51. WHO. Principles for the assessment of risk to human health from exposure to chemicals. International Programme on Chemical Safety. Environmental Health Criteria 210. Geneve: World Health Organization; 1999.
52. Sinkkonen S, Lahtipera M, Vattulainen A, Takhistov W, Viktorovskii IV, Utsal VA, et al. Analyses of known and new types of polyhalogenated aromatic substances in oven ash from recycled aluminium production. Chemosphere 2003;52:761-75.
53. Jongeneelen FJ. Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann Occup Hyg 2001;45:3-13.
54. Rappaport SM, Waidyanatha S, Serdar B. Naphthalene and its biomarkers as measures of occupational exposure to polycyclic aromatic hydrocarbons. J Environ Monit 2004;6:413-6.
55. Pavanello S, Clonfero E. Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies. G Ital Med Lav Ergon 2004;26:311-21.
56. Riihimaki V, Hanninen H, Akita R, Kovala T, Kuosma E, Paakkulainen H, et al. Body burden of aluminium in relation to central nervous system function among metal inert-gas welders. Scand J Work Environ Health 2000;26:118-23.
57. Elinder CG, Ahrengart L, Lidums V, Pettersson E, Sjogren B. Evidence of aluminium accumulation in aluminium welders. Br J Ind Med 1991;48:735-8.
58. Arsalane K, Broeckaert F, Knoops B, Clippe A, Buchet JP, Bernard A. Increased serum and urinary concentrations of lung clara cell protein in rats acutely exposed to ozone. Toxicol Appl Pharmacol 1999;159:169-74.
59. Bergamaschi E, Apostoli P, Catalani S, Festa D, Folesani G, Andreoli R, et al. Indicators of pulmonary epithelial damage among workers at a foundry exposed to airborne pollutants. G Ital Med Lav Ergon 2003;25:104-6.
60. ++ superoxide dismutase activities, and the seventy of coal workers' pneumoconiosis. Occup Environ Med 1998;55:533-40.
61. Chen LC, Hang Z, Myers AC, Huang SK. Cutting edge: Altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa protein. J Immunol 2001;167:3025-8.
62. Quarcoo D, Schulte-Herbruggen O, Lommatzsch M, Schierhorn K, Hoyle GW, Renz H, et al. Nerve growth factor induces increased airway inflammation via a neuropeptide-dependent mechanism in a transgenic animal model of allergic airway inflammation. Clin Exp Allergy 2004;34:1146-51.
63. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 2001;54:577-89.
64. Rossi RE, Monasterolo G. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 2004;133:261-6.
65. Monteseirin J, Bonilla I, Camacho MJ, Conde J, Sobrino F. IgE-dependent release of myeloperoxidase by neutrophils from allergic patients. Clin Exp Allergy 2001;31:889-92.
66. Kristjansson S, Shimizu T, Strannegard IL, Wennergren G. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and utopie dermatitis. Pediatr Allergy Immunol 1994;5:223-9.
67. Nielsen GD, Olsen O, Larsen ST, Lovik M, Poulsen LK, Glue C, et al. IgE-mediated sensitisation, rhinits and asthma from occupational exposures. Smoking as a model for airborne adjuvants? Toxicology 2005;216:87-105.
68. Clausen SK, Bergqvist M, Poulsen LK, Poulsen OM, Nielsen GD. Development of sensitisation or tolerance following repeated OVA inhalation in BALB/cJ mice. Dose-dependency and modulation by the Al(OH)3 adjuvant. Toxicology 2003;184:51-68.
69. Fujimaki H, Ozawa M, Ashikawa T, Kubota K, Watanabe N. Induction of IgE antibody production to aerosolized ovalbumin in mice treated intratracheally with aluminum silicate. Int Arch Allergy Appl Immunol 1986;79:206-10.
70. Sorgdrager B, Pal TM, deLooff AJ, Dubois AE, deMonchy JG. Occupational asthma in aluminium potroom workers related to pre-employment eosinophil count. Eur Respir J 1995;8:1520-4.
71. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophil inflammation in severe persistent asthma. Am J Resp Crit Care Med 1999;160:1532-9.
72. Schwarz Y, Kivity S, Fischbein A, Abraham JL, Fireman E, Moshe S, et al. Evaluation of workers exposed to dust containing hard metals and aluminum oxide. Am J Ind Med 1998;34:177-82.
73. Watters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, et al. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1198;35:696-704.
74. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990;142:642-7.
75. Fujimoto K, Kubo K, Yamaguchi S, Honda T, Matsuzawa Y. Eosinophil activation in patients with pulmonary fibrosis. Chest 1995;108:48-54.
76. Eklund A, Arns R, Blaschke E, Hed J, Hjertquist SO, Larsson K, et al. Characteristic of alveolar cells and soluble components in bronchoalveolar lavage fluid from non-smoking aluminium potroom workers. Br J Ind Med 1989;46:782-6.
77. Riise GC, Ahlsedt S, Larsson S, Enander I, Jones I, Larsson P, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995;50:360-5.
78. Werle E, Jakel HP, Muller A, Fischer H, Fiehn W, Eich W. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. Clint Lab 2005;51:11-9.
79. Huang JY, Huang CC, Lim PS, Wu MS, Leu ML. Effect of body iron stores on serum aluminum level in hemodialysis patients. Nephron 1992;61:158-62.
80. Van Landegheim GF, D'H'aese PC, Lamberts LV, De Broe ME. Competition of iron and aluminium for transferrin: the molecular basis for aluminium deposition in iron-overloaded dialysis patients? Exp Nephrol 1997;5:239-45.
81. Mutze S, Hebling U, Stremmel W, Wang J, Arnhold J, Pantopoulos K, et al. Myeloperoxidase-derived hypochlorous acid antagonizes the oxidative stress-mediated activation of iron regulatory protein 1. J Biol Chem 2003;278:40542-9.
82. Meredith PA, Moore MR, Goldberg A. Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme 1977;22:22-7.
83. Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, et al. Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 1989;36:852-8.
84. Rosenlof K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminium, and anaemia in patients on haemodialysis. Lancet, 1999;335:247-9.
85. Chmielnicka J, Nasiadek M, Lewandowska-Zyndul E. The effect of aluminum chloride on some steps of heme biosynthesis in rats after oral exposure. Biol Trace Elem Res 1994; 40:127-36.
86. Drueke TB. Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis 1991;18:87-92.
87. Allain P, Leblondel G, Mauras Y. Effect of aluminum and deferoxamine on biliary iron elimination in the rat. Proc Soc Exp Biol Med 1988;188:471-3.
88. Nasiadek M, Chmielnicka J. Interaction of aluminum with exogenous and endogenous iron in the organism of rats. Ecotoxicol Environ Saf 2000;45:284-90.
89. Guo C., Huang CJ, Chiou YL, Hsu GS. Alteration of trace element distribution and testis ACE activity in mice with high peritoneal aluminum. Biol Trace Elem Res 2002;86:145-57.
90. Bazzoni GB, Bollini AN, Hernandez GN, Contini-Mdel C, Chiarotto MM, Rasia ML. In vivo effect of aluminium upon the physical properties of the erythrocyte membrane. J Inorg Biochem 2005;99:822-7.
91. Umland TC, Swaminathan S, Singh G, Warty V, Furey W, Pletcher J, et al. Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A resolution. Nat Struct Biol 1994;8:538-45.
92. Haug A, Shi B, Vitorello V. Aluminium interactions with phosphoinositide-associated signal transduction. Arch Toxicol 1994;68:1-7.
93. Jones DI, Kochian LV. Aluminium interaction with plasma membrane lipids and enzyme metal binding sites and its potential role in Al. Cytotoxicity FEBS Lett 1997;400:51-7.
94. Ibrahim AM, Funkhouser JD. Phoshatidylinositol transfer protein in lung: cellular and subcellular localization. J Histochem Cytochem 1997;45:551-8.
95. Halatek T, Sinczuk-Walczak H, Rydzynski K. Prognostic significance of low serum levels Clara cells phospholipid-binding protein in occupational aluminium neurotoxicity J Inorg Biochem 2005;99:1904-11.
96. Alessio L, Apostoli P, Ferioli A, Di Sipio I, Mussi I, Rigosa C, Albertini A. Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers. Med Lav 1989;80:290-300.
97. Deutsche Forschungsgemeinschaft - List of MAK and BAT values 2003. Maximum concentration and biological tolerance values at the workplace. Weinheim: Wiley_VCH Verlag; 2003.
98. Ordinance of the minister of state economy and labour on the maximum permissible concentrations and intensities of harmful agents in the work environment. J Law Rep Poland 2005,212,1769 [in Polish].
99. Biomonitoring of exposure to chemicals [cited Aug 25, 2006]. Helsinki: Finnish Institute of Occupational Health; 1996. Available from http://www.ttl.fi.
100. Benke G, Abramson M, Sim M. Exposures in the alumina and primary aluminium industry: an historical review. Ann Occup Hyg 1989;42:173-89.
101. Westberg HB, Selden AI, Bellander T. Exposure to Chemical Agents inSwedishaluminumfoundriesandaluminumremeltingplants - Acomprehensive survey. Appl Occup Environ Hygiene 2001;16:66-77.